Phenotype: Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2


OMIM: 613156
Inheritance: Autosomal recessive
Classification: Diseases of the nervous system

Related informations: Orphanet    Gene Tests    Clinical Synopsis    Clinical Trials

POMT2 || c.1997A>G

Gene/Locus:    POMT2
Dna Change:    c.1997A>G
Protein Change:    p.Tyr666Cys
Mutation Type:    Substitution
Mutation Effect:    Missense
Location:    exon 19
Transcript:    NM_013382.5

PopulationEthnic GroupRegionMutation FrquencyCoalescence TimeReference
FranceNANA3 patients/ 3 familiesNAYanagisawa A et al., 2007Yanagisawa A, Bouchet C, Van den Bergh PY, Cuisset JM, Viollet L, Leturcq F, Romero NB, Quijano-Roy S, Fardeau M, Seta N, Guicheney P, . New POMT2 mutations causing congenital muscular dystrophy: identification of a founder mutation.. Neurology. 2007; 69(12):1254-60
MoroccoNANA1 patient/1 familyNAYanagisawa A et al., 2007Yanagisawa A, Bouchet C, Van den Bergh PY, Cuisset JM, Viollet L, Leturcq F, Romero NB, Quijano-Roy S, Fardeau M, Seta N, Guicheney P, . New POMT2 mutations causing congenital muscular dystrophy: identification of a founder mutation.. Neurology. 2007; 69(12):1254-60

References

Yanagisawa A, Bouchet C, Van den Bergh PY, Cuisset JM, Viollet L, Leturcq F, Romero NB, Quijano-Roy S, Fardeau M, Seta N, Guicheney P, New POMT2 mutations causing congenital muscular dystrophy: identification of a founder mutation.Neurology. 2007; 69(12):1254-60